mrr pvt. Ltd.

Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America

Press Release   •   Feb 06, 2017 14:26 IST

p { margin-bottom: 0.25cm; line-height: 120%; }a:link { }

Cervical cancer is one of the most common causes of cancer death for North American women. It is estimated that over 4,000 women in the United States and 400 women in Canada die from cervical cancer in 2016. However, it is also one of the most preventable types of cancer. Pap smear and HPV DNA test are two most popular testing methods to diagnose cervical cancer cases in North America. United States is the leader in North America cervical cancer test market. It holds over 90 percent testing population share alone, and is likely to maintain its position in forecasting period as well due to women getting regular Pap tests.

Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America report published by Renub Research provides a comprehensive analysis and forecast till 2020. This report provides a complete analysis of 2 Countries Cervical Cancer Test Market & Number of Cervical Cancer Population. All the 2 countries in the report have been studied from 3 viewpoints.

North America Cervical Cancer Test Market, Volume & Mortality

Cervical cancer Test Population (2008-2020)

Pap smear test population (2008-2020)

HPV DNA test population (2008-2020)

Cervical Cancer Mortality Population (2001-2011)

Cervical Cancer Test Market (2008-2020)

Pap smear test market (2008-2020)

HPV DNA test market (2008-2020)

Countries studied in the report are as follows

United States

Canada

Data Sources

Download Sample Copy of This Report at: http://www.marketresearchreports.biz/sample/sample/948213